Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China

被引:4
|
作者
Yan, Zhihui [1 ,2 ]
Chen, Yuan [1 ]
Chen, Chunfu [1 ]
Li, Congcong [1 ]
Diao, Xiaojun [1 ]
机构
[1] Shandong Univ, Prov Hosp, Dept Neurol, Jinan 250021, Shandong, Peoples R China
[2] Yantaishan Hosp, Dept Neurol, Yantai 264001, Shandong, Peoples R China
关键词
Medication-overuse headache; Relapse; Risk factors; Non-conditional multivariate stepwise logistic regression; MIGRAINE; FEATURES;
D O I
10.1186/s12883-015-0422-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Medication overuse headache (MOH) is the third most prevalent headache type after migraine and tension-type headache. A large number of studies on the long-term prognosis have shown that MOH has a high relapse rate after treatment. Although MOH relapse-related risk factors have been reported, no related research has been performed in China. Therefore, the purpose of this study was to analyze and evaluate the risk factors for MOH relapse in China. Methods: Eighty-six out-patients of Shandong Provincial Hospital who were initially diagnosed with MOH, and who had successful withdrawal treatment within 2 months, were chosen from March 2012 to July 2013. All subjects were followed up by the investigators of this study. Of the 86 subjects, 27 who had relapsed were compared with 59 who had not relapsed (i.e. the controls). Based on a standardized questionnaire, a database was created (with Microsoft Excel 2010). The data, which included 38 indexes, were analyzed by univariate analysis with chi-square test, Fisher's exact test, t-test, or paired rank test. The statistically correlated (P < 0.05) variables were chosen as the independent variables, thereby enabling the calculation of the non-conditional multivariate stepwise logistic regression. Results: The independent risk factors for medication-overuse headache relapse were determined as headache frequency before drug withdrawal, duration of primary headache, and headache frequency after drug withdrawal. Conclusion: Headache frequency before drug withdrawal, duration of primary headache, and headache frequency after drug withdrawal may be the independent risk factors for MOH relapse in China.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [1] Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China
    Zhihui Yan
    Yuan Chen
    Chunfu Chen
    Congcong Li
    Xiaojun Diao
    BMC Neurology, 15
  • [2] Rates and Predictors of Relapse in Medication Overuse Headache: A Clinic-Based Study from China
    Liu, Huanxian
    Zhang, Meichen
    Chen, Xiaoyan
    Sun, Shuping
    Dong, Zhao
    Yu, Shengyuan
    EUROPEAN NEUROLOGY, 2020, 82 (4-6) : 68 - 74
  • [3] Analysis on the risk factors of medication-overuse headache in Chinese patients
    Li, Junxia
    Chen, Chunfu
    Zhang, Ligong
    Cui, Xiaochen
    Wei, Chuanqiao
    Diao, Xiaojun
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 48 : 153 - 159
  • [4] Medication-overuse headache: risk factors, pathophysiology and management
    Diener, Hans-Christoph
    Holle, Dagny
    Solbach, Kasja
    Gaul, Charly
    NATURE REVIEWS NEUROLOGY, 2016, 12 (10) : 575 - 583
  • [5] Medication-overuse headache: risk factors, pathophysiology and management
    Hans-Christoph Diener
    Dagny Holle
    Kasja Solbach
    Charly Gaul
    Nature Reviews Neurology, 2016, 12 : 575 - 583
  • [6] Medication-overuse headache: Description, treatment, and relapse prevention
    Grazzi L.
    Andrasik F.
    Current Pain and Headache Reports, 2006, 10 (1) : 71 - 77
  • [7] Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China
    He, Z.
    Dong, L.
    Zhang, Y.
    Kong, Q.
    Tan, G.
    Zhou, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (08) : 1228 - 1234
  • [8] Diagnostic Delay of Chronic Migraine and Medication-Overuse Headache in University-Based Headache Clinic
    Puvvadi, Pooja
    Schorn, Melissa
    Krashin, Daniel
    Murinova, Natalia
    NEUROLOGY, 2018, 90
  • [9] Clinical and psychological factors associated to medication-overuse headache
    Viana, Michele
    Bottiroli, Sara
    Sances, Grazia
    Martinelli, Daniele
    Sandrini, Giorgio
    Nappi, Giuseppe
    Tassorelli, Cristina
    CEPHALALGIA, 2017, 37 : 142 - 142
  • [10] Health risk behaviours in medication-overuse headache: results of a population-based study
    Westergaard, M.
    Glumer, C.
    Hansen, E. Holme
    Jensen, R. J.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15